dexamethasone 17-valerate,
dexamethasone valerate,
Dexamethasone valerate,
33755-46-3,
Dexamethasone 17-valerate,
DV-17,
UNII-OI7CP949NN,
EINECS 251-669-2,
OI7CP949NN,
Dexamethasone valerate [JAN],
9-Fluoro-11beta,17,21-trihydroxy-16alpha-methylpregna-1,4-diene-3,20-dione 17-valerate,
NCGC00159316-02,
DSSTox_CID_2904,
DSSTox_RID_76782,
DSSTox_GSID_22904,
Dexamethasone valerate (JAN),
Pregna-1,4-diene-3,20-dione, 9-fluoro-11-beta,17,21-trihydroxy-16-alpha-methyl-, 17-valerate,
CAS-33755-46-3,
NCGC00274064-01,
Betamethasone Valerate EP Impurity C,
Dexamethasone Valarate,
Voalla ointment (TN),
SCHEMBL124723,
CHEMBL1378167,
DTXSID3022904,
CHEBI:135770,
ZINC3882051,
Tox21_111565,
AKOS032429285,
Tox21_111565_1,
MCULE-1282205271,
LS-118480,
D01948,
Q27285667,
9-fluoro-11ss,17,21-trihydroxy-16a-methylpregna-1,4-diene-3,20-dione 17-valerate,
9-Fluoro-11?,21-dihydroxy-16?-methyl-3,20-dioxopregna-1,4-dien-17-yl pentanoate ;DV 17; Dexamethasone 17-valerate; 9-Fluoro-11?,17,21-trihydroxy-16?-methyl-pregna-1,4-diene-3,20-dione 17-Valerate; Betamethasone Valerate EP Impurity C,
Voalla ointment,
AC1L1Y9P,
BETAMETHASONE VALERATE,
C27H37FO6,
CID63047,
C27-H37-F-O6,
CS-O-13613,
[(8S,9R,10S,11S,13S,14S,16R,17R)-9-fluoro-11-hydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] pentanoate,
Pregna-1,4-diene-3,20-dione, 9-fluoro-11,21-dihydroxy-16-methyl-17-[(1-oxopentyl)oxy]-, (11.beta.,16.alpha.)-,